Health — 08 October 2013

By Richard Lenti

Researchers are calling it a breakthrough – a first-of-its-kind imaging tool to detect myelin damage in people suffering from multiple sclerosis (MS).  The test could help physicians diagnose MS earlier, monitor the disease’s progression, and evaluate the effectiveness of treatment.

Scientists at Cleveland’s Case Western Reserve University School of Medicine have developed a molecular probe that can be detected by positron emission tomography (PET) imaging. The new molecular marker, called MeDAS, offers the first non-invasive visualization of myelin integrity of the entire spinal cord.

“While MS originates in the immune system, the damage occurs to the myelin structure of the central nervous system,” said Yanming Wang, PhD, associate professor of radiology and senior author of the study published in the journal Annals of Neurology.

The traditional imaging test for diagnosing MS is magnetic resonance imaging (MRI), which can show inflammation and is helpful at diagnosing the disease in its early stages, but cannot accurately track its progression.

Read more at National Pain Report.


About Author

Richard Lenti

Richard Lenti has worked as a news writer for the last 20 years at various television stations in Los Angeles. He is a Golden Mike winner and a graduate of California State University, Fresno. With roots in print journalism, Richard is excited to be “published” once again; having people read his work as opposed to having it read to them. As a freelance writer his work has appeared in the Easy Reader, L.A. Jazz Scene, Irrigation and Green Industry, and the KCAL 9 Online website.

(0) Readers Comments

Comments are closed.